Glucose and insulin responses to monk fruit-based sweetener formulations and their effects on appetite, liking and wanting, and energy intake (GREEN): a randomized double-blind, crossover study.

Eur J NutrOct 31, 2026 (epub)

Jakkrit Aisara, Mingkwan Na Takuathung, Kantirat Yaja et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized, double-blind, crossover study compared three monk fruit-based sweetener formulations (MF1–MF3) with sucrose and sucralose in 30 healthy adults. Participants consumed each sweetened beverage before a standardized meal, with glucose and insulin measured over 180 min and appetite, liking, energy intake, and adverse events assessed. Preload glucose and insulin responses were lower with MF1–MF3 and sucralose than with sucrose; postprandial responses were comparable across sweeteners, while overall glucose and insulin iAUCs were lower with MF1–MF3. Appetite and energy intake did not differ, but diarrhea occurred more often with MF1–MF3.

Key findings

  • Preload glycemic and insulinemic responses were significantly lower with MF1–MF3 and sucralose than with sucrose.
  • Postprandial glucose and insulin responses were comparable across all sweeteners; overall glucose and insulin iAUCs were lower with MF1–MF3.
  • Appetite responses and energy intake did not differ among sweeteners, although MF1 had lower liking and wanting scores.
  • Adverse events were mild, with diarrhea occurring more frequently with MF1–MF3.

Why it matters

The findings suggest that these monk fruit-based formulations can produce different acute glucose and insulin responses from sucrose without measurable differences in appetite or energy intake in healthy adults. The more frequent diarrhea and lower liking and wanting for MF1 are relevant when considering tolerability and acceptability. The study informs short-term responses, not longer-term metabolic or dietary effects.

What to keep in mind

The study assessed acute responses in 30 healthy adults; it does not establish longer-term effects or responses in other populations.

Source

Published in Eur J Nutr. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Endocrinology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.